P
Peter Simmonds
Researcher at University of Oxford
Publications - 857
Citations - 69113
Peter Simmonds is an academic researcher from University of Oxford. The author has contributed to research in topics: Hepatitis C virus & Virus. The author has an hindex of 131, co-authored 823 publications receiving 62953 citations. Previous affiliations of Peter Simmonds include John Radcliffe Hospital & Edinburgh Royal Infirmary.
Papers
More filters
Journal ArticleDOI
Use of Nucleotide Composition Analysis To Infer Hosts for Three Novel Picorna-Like Viruses
Amit Kapoor,Peter Simmonds,Walter Ian Lipkin,Syed Sohail Zahoor Zaidi,Eric Delwart,Eric Delwart +5 more
TL;DR: Phylogenetic analysis indicated that these viruses belong to the picorna-like virus superfamily, and nucleotide composition analysis (NCA) provided a rapid and robust method to identify their likely cellular hosts.
Journal ArticleDOI
Hepatitis C virus : epidemiology and genotypes in the north east of England
Jonathan P Watson,A M Brind,C E Chapman,C L Bates,F K Gould,Sarah J. Johnson,Alastair D. Burt,J C Ferguson,Peter Simmonds,Margaret F. Bassendine +9 more
TL;DR: The epidemiology of hepatitis C virus (HCV) infection was studied in an English teaching hospital over an 18 month period and patients with subtype 1b had significantly more severe liver disease than other genotypes when the histological activity index scores for fibrosis were analysed.
Journal ArticleDOI
Continuous high-frequency observations of hydrogen at the Mace Head baseline atmospheric monitoring station over the 1994-1998 period
Peter Simmonds,Richard G. Derwent,Simon O'Doherty,DB Ryall,L. P. Steele,Ray L. Langenfelds,Peter K. Salameh,HC Wang,CH Dimmer,Lorraine Hudson +9 more
TL;DR: For example, the Mace Head atmospheric research station on the Atlantic Ocean coast of Ireland has been continuously collecting high-frequency (every 40-min) automatic measurements of hydrogen from 1994 to 1998.
Journal ArticleDOI
The effects of illicit drugs on the HIV infected brain
TL;DR: This review traces progress in understanding the pathogenesis of HIV related CNS disorders before the introduction of effective therapy and compares the state of the authors' knowledge now that effective therapy has significantly modified disease progression.